How to handle an industry in disruption: Intervene or laissez-faire?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25947160.
- Also identified by DOI 10.1126/scitranslmed.aaa3679.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An analysis of four regions in four countries suggests that the best way to mitigate disruption of the pharmaceutical industry is not to ignore or stem it but to sponsor initiatives that keep scientists engaged.
Medical subject headings
- Drug Industry
- Leadership